RIGL · Healthcare · $891M
$48.15-1.51%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 매출 $79M — 전 분기 $59M에서 급반등했고 1년 전보다도 14% 늘었어요.”
In the company's words · 2026 2분기 earnings call